These results suggest that PNPLA3 genotype could be used as a tool to stratify the risk for HCC in combination with other well-known risk factors, e.g., liver function tests, portal hypertension, and its surrogates. The gene discussed is PNPLA3; the disease is hepatocellular carcinoma.